150 related articles for article (PubMed ID: 31675090)
1. Talking the Talk About Tumor Genomic Testing.
Schilsky RL
J Natl Cancer Inst; 2020 May; 112(5):436-437. PubMed ID: 31675090
[No Abstract] [Full Text] [Related]
2. Factors Associated With Oncologist Discussions of the Costs of Genomic Testing and Related Treatments.
Yabroff KR; Zhao J; de Moor JS; Sineshaw HM; Freedman AN; Zheng Z; Han X; Rai A; Klabunde CN
J Natl Cancer Inst; 2020 May; 112(5):498-506. PubMed ID: 31675070
[TBL] [Abstract][Full Text] [Related]
3. Oncologists' Perceptions of Tumor Genomic Profiling and the Communication of Test Results and Risks.
Hall MJ; D'Avanzo P; Chertock Y; Brajuha J; Bass SB
Public Health Genomics; 2021; 24(5-6):304-309. PubMed ID: 34325422
[TBL] [Abstract][Full Text] [Related]
4. Utilization of tumor genomics in clinical practice: an international survey among ASCO members.
Barroso-Sousa R; Guo H; Srivastava P; James T; Birch W; Siu LL; Tew WP; Tolaney SM
Future Oncol; 2019 Jul; 15(21):2463-2470. PubMed ID: 31238721
[No Abstract] [Full Text] [Related]
5. Importance of Patient Health Insurance Coverage and Out-of-Pocket Costs for Genomic Testing in Oncologists' Treatment Decisions.
Yabroff KR; Sylvia Shi K; Zhao J; Freedman AN; Zheng Z; Nogueira L; Han X; Klabunde CN; de Moor JS
JCO Oncol Pract; 2024 Mar; 20(3):429-437. PubMed ID: 38194620
[TBL] [Abstract][Full Text] [Related]
6. Genetic and genomic learning needs of oncologists and oncology nurses in the era of precision medicine: a scoping review.
Rahman B; McEwen A; Phillips JL; Tucker K; Goldstein D; Jacobs C
Per Med; 2022 Mar; 19(2):139-153. PubMed ID: 35060769
[TBL] [Abstract][Full Text] [Related]
7. Genomic testing: a struggle for oncologists.
Hede K
J Natl Cancer Inst; 2014 Jun; 106(6):dju172. PubMed ID: 24907388
[No Abstract] [Full Text] [Related]
8. Community oncologists' perceptions and utilization of large-panel genomic tumor testing.
Anderson EC; Hinton AC; Lary CW; Fenton ATHR; Antov A; Edelman E; Helbig P; Reed K; Miesfeldt S; Thomas CA; Hall MJ; Roberts JS; Rueter J; Han PKJ;
BMC Cancer; 2021 Nov; 21(1):1273. PubMed ID: 34823486
[TBL] [Abstract][Full Text] [Related]
9. The current clinical value of genomic instability.
Diaz LA
Semin Cancer Biol; 2005 Feb; 15(1):67-71. PubMed ID: 15613290
[TBL] [Abstract][Full Text] [Related]
10. Tumor genome analysis includes germline genome: are we ready for surprises?
Catenacci DV; Amico AL; Nielsen SM; Geynisman DM; Rambo B; Carey GB; Gulden C; Fackenthal J; Marsh RD; Kindler HL; Olopade OI
Int J Cancer; 2015 Apr; 136(7):1559-67. PubMed ID: 25123297
[TBL] [Abstract][Full Text] [Related]
11. When Should Tumor Genomic Profiling Prompt Consideration of Germline Testing?
DeLeonardis K; Hogan L; Cannistra SA; Rangachari D; Tung N
J Oncol Pract; 2019 Sep; 15(9):465-473. PubMed ID: 31509718
[TBL] [Abstract][Full Text] [Related]
12. Exome sequencing disclosures in pediatric cancer care: Patterns of communication among oncologists, genetic counselors, and parents.
Scollon S; Majumder MA; Bergstrom K; Wang T; McGuire AL; Robinson JO; Gutierrez AM; Lee CH; Hilsenbeck SG; Plon SE; Parsons DW; Street RL
Patient Educ Couns; 2019 Apr; 102(4):680-686. PubMed ID: 30482469
[TBL] [Abstract][Full Text] [Related]
13. Physician Experiences and Understanding of Genomic Sequencing in Oncology.
Weipert CM; Ryan KA; Everett JN; Yashar BM; Chinnaiyan AM; Scott Roberts J; De Vries R; Zikmund-Fisher BJ; Raymond VM
J Genet Couns; 2018 Feb; 27(1):187-196. PubMed ID: 28840409
[TBL] [Abstract][Full Text] [Related]
14. Utilization of genomic testing in advanced non-small cell lung cancer among oncologists in the Veterans Health Administration.
Arney J; Helm A; Crook T; Braun UK; Chen GJ; Hayes TG
Lung Cancer; 2018 Feb; 116():25-29. PubMed ID: 29413047
[TBL] [Abstract][Full Text] [Related]
15. Ethics and genomic medicine, how to navigate decisions in surgical oncology.
Devon KM; Lerner-Ellis JP; Ganai S; Angelos P
J Surg Oncol; 2015 Jan; 111(1):18-23. PubMed ID: 25183289
[TBL] [Abstract][Full Text] [Related]
16. Tumor-only sequencing for oncology management: Germline-focused analysis and implications.
George A; Turnbull C
Genes Chromosomes Cancer; 2021 May; 60(5):352-357. PubMed ID: 33222309
[TBL] [Abstract][Full Text] [Related]
17. Integrated patient and tumor genetic testing for individualized cancer therapy.
Hertz DL; McLeod HL
Clin Pharmacol Ther; 2016 Feb; 99(2):143-6. PubMed ID: 26537014
[TBL] [Abstract][Full Text] [Related]
18. Issues Arising in Psychological Consultations to Help Parents Talk to Minor and Young Adult Children about their Cancer Genetic Test Result: a Guide to Providers.
Patenaude AF; Schneider KA
J Genet Couns; 2017 Apr; 26(2):251-260. PubMed ID: 27699628
[TBL] [Abstract][Full Text] [Related]
19. Oncologist-Reported Reasons for Not Ordering Multimarker Tumor Panels: Results From a Nationally Representative Survey.
Roberts MC; Spees LP; Freedman AN; Klein WMP; Prabhu Das I; Butler EN; de Moor JS
JCO Precis Oncol; 2021; 5():. PubMed ID: 34250411
[TBL] [Abstract][Full Text] [Related]
20. Views of Adolescents and Young Adults with Cancer and Their Oncologists Toward Patients' Participation in Genomic Research.
Gutierrez AM; Robinson JO; Raesz-Martinez R; Canfield I; Majumder MA; Scollon S; Desrosiers LR; Hsu RL; Allen-Rhoades W; Parsons DW; Plon SE; McGuire AL; Malek J
J Adolesc Young Adult Oncol; 2023 Oct; 12(5):773-781. PubMed ID: 36595372
[No Abstract] [Full Text] [Related]
[Next] [New Search]
